How can an academic scientist honour knowledge for its own sake, while also using knowledge as a means to generate wealth? This text investigates the trends & effects of modern, commercialised academic science.
A clever, thought-provoking look at the biological roots of economics -- Kealey’s insightful work illuminates in the tradition of Richard Dawkins, Steven Pinker and Jared Diamond. In this highly original work, the author makes a groundbreaking and exciting connection between the evolutionary and economic history of humanity. He explains how the roots of barter, trade and the contract are embedded in human nature, and how markets work on the evolutionary patterns of natural selection. Splendidly multi-faceted, the book travels across human history from Neolithic times, through Ancient Egypt and the Renaissance European explorers, to the failure of the Soviet economy in recent years. Through this journey Kealey skillfully demonstrates how an understanding of biology and natural selection radically transforms our view of economics, business, technology and the economic history of the human species. This exceptional study will appeal to anyone who enjoys popular science, history or serious business books.Sex, Science and Profitsis witty, magnificent, thought- provoking and provocative. It promises to be an important and highly controversial book. From the Hardcover edition.
For the first time in paperback and with a new introduction. Discover how and why the government is corrupting scientific research. When Speaker Newt Gingrich greeted Dr. David Lewis in his office overlooking the National Mall, he looked at Dr. Lewis and said: “You know you’re going to be fired for this, don’t you?” “I know,” Dr. Lewis replied, “I just hope to stay out of prison.” Gingrich had just read Dr. Lewis’s commentary in Nature, titled “EPA Science: Casualty of Election Politics.” Three years later, and thirty years after Dr. Lewis began working at EPA, he was back in Washington to receive a Science Achievement Award from Administrator Carol Browner for his second article in Nature. By then, EPA had transferred Dr. Lewis to the University of Georgia to await termination—the Agency’s only scientist to ever be lead author on papers published in Nature and Lancet. The government hires scientists to support its policies; industry hires them to support its business; and universities hire them to bring in grants that are handed out to support government policies and industry practices. Organizations dealing with scientific integrity are designed only to weed out those who commit fraud behind the backs of the institutions where they work. The greatest threat of all is the purposeful corruption of the scientific enterprise by the institutions themselves. The science they create is often only an illusion, designed to deceive; and the scientists they destroy to protect that illusion are often our best. This book is about both, beginning with Dr. Lewis’s experience, and ending with the story of Dr. Andrew Wakefield. This new edition, now for the first time in paperback, features a new introduction by the author.
In recent years the news media have been awash in stories about increasingly close ties between college campuses and multimillion-dollar corporations. Our nation’s universities, the story goes, reap enormous windfalls patenting products of scientific research that have been primarily funded by taxpayers. Meanwhile, hoping for new streams of revenue from their innovations, the same universities are allowing their research—and their very principles—to become compromised by quests for profit. But is that really the case? Is money really hopelessly corrupting science? With Science for Sale, acclaimed journalist Daniel S. Greenberg reveals that campus capitalism is more complicated—and less profitable—than media reports would suggest. While universities seek out corporate funding, news stories rarely note that those industry dollars are dwarfed by government support and other funds. Also, while many universities have set up technology transfer offices to pursue profits through patents, many of those offices have been financial busts. Meanwhile, science is showing signs of providing its own solutions, as highly publicized misdeeds in pursuit of profits have provoked promising countermeasures within the field. But just because the threat is overhyped, Greenberg argues, doesn’t mean that there’s no danger. From research that has shifted overseas so corporations can avoid regulations to conflicts of interest in scientific publishing, the temptations of money will always be a threat, and they can only be countered through the vigilance of scientists, the press, and the public. Based on extensive, candid interviews with scientists and administrators, Science for Sale will be indispensable to anyone who cares about the future of scientific research.
A book with historical scope and unsettling revelations, "Prescription for Profit" shows how the lure of huge profits has dramatically changed medical research. Marsa chronicles the extraordinary rise of the American pharmaceutical industry, from the mass production of penicillin during World War II to the heady postwar days when vast government grants helped scientists conquer polio and crack the genetic code. of photos.
This trenchant study analyzes the rise and decline in the quality and format of science in America since World War II. Science-Mart attributes this decline to a powerful neoliberal ideology in the 1980s which saw the fruits of scientific investigation as commodities that could be monetized, rather than as a public good.
In Profit From Science , author George Danner presents solutions to the big problems that modern business face solutions that are grounded in logic and empiricism. This book instructs business leaders in how to add the discipline and technical precision of the scientific method to their strategic planning and decision making.
"Opioids. Concussions. Obesity. Climate change. America is a country of everyday crises -- big, long-spanning problems that persist, mostly unregulated, despite their toll on the country's health and vitality. And for every case of government inaction on one of these issues, there is a set of familiar, doubtful refrains: The science is unclear. The data is inconclusive. Regulation is unjustified. It's a slippery slope. Is it? The Triumph of Doubt traces the ascendance of science-for-hire in American life and government, from its origins in the tobacco industry in the 1950s to its current manifestations across government, public policy, and even professional sports. Well-heeled American corporations have long had a financial stake in undermining scientific consensus and manufacturing uncertainty; in The Triumph of Doubt, former Obama and Clinton official David Michaels details how bad science becomes public policy -- and where it's happening today. Amid fraught conversations of "alternative facts" and "truth decay," The Triumph of Doubt wields its unprecedented access to shine a light on the machinations and scope of manipulated science in American society. It is an urgent, revelatory work, one that promises to reorient conversations around science and the public good for the foreseeable future"--Provided by publisher.
Did you ever wonder whether doctors want cures, or just treatments?Did you know ... This book reviews recent key, hard-won successes and findings from recent biomedical research. Written by one of the most ardent defenders of the public trust in science, it provides an accessible, detailed look at successes in translational biomedical and clinical research. The author provides an optimistic, forward-looking view for the possibility of change for the public good, cutting through the controversy and gets to very core of each topic. The public can be optimistic about the future of medicine, but only if they learn the facts of these advances, and learn what their doctors should be expected to know.Highly referenced, and filled with interviews from experts and people directly involved in the research behind the new facts in each chapter, this book is a rich source of information on advances in biomedicine that you will want to share with your family & friends.
The past two decades have seen a gradual but noticeable change in the economic organization of innovative activity. Most firms used to integrate research and development with activities such as production, marketing, and distribution. Today firms are forming joint ventures, research and development alliances, licensing deals, and a variety of other outsourcing arrangements with universities, technology-based start-ups, and other established firms. In many industries, a division of innovative labor is emerging, with a substantial increase in the licensing of existing and prospective technologies. In short, technology and knowledge are becoming definable and tradable commodities. Although researchers have made significant advances in understanding the determinants and consequences of innovation, until recently they have paid little attention to how innovation functions as an economic process. This book examines the nature and workings of markets for intermediate technological inputs. It looks first at how industry structure, the nature of knowledge, and intellectual property rights facilitate the development of technology markets. It then examines the impacts of these markets on firm boundaries, the division of labor within the economy, industry structure, and economic growth. Finally, it examines the implications of this framework for public policy and corporate strategy. Combining theoretical perspectives from economics and management with empirical analysis, the book also draws on historical evidence and case studies to flesh out its research results.